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Keloids and hypertrophic scars are signi®cant symp-
tomatic clinical problems characterized by excess
collagen. Although extensive research has focused on
®broblasts and collagen turnover in these aberrant
scars, little work has been done on the expression of
integrins (cell membrane structures that link cells to
extracellular matrix) within these lesions. Integrin-
mediated regulation of collagen synthesis has previ-
ously been observed in explanted ®broblasts from
normal and ®brotic dermis, and integrin a1 knock-
out mice maintain increased collagen synthesis con-
sistent with a role for a1b1 in providing negative
feedback on collagen synthesis. These ®ndings sug-
gested the need to evaluate integrin roles in keloids
and hypertrophic scars. In this study we examined
integrin expression in keloids (n = 11), hypertrophic
scars (n = 5), radiation ulcers (n = 2), and normal
skin specimens (n = 8). We used a novel approach to
analysis by isolating dermal ®broblasts directly from
tissue (without explant culture) and determining sur-
face integrin expression by ¯ow cytometry. We
found that keloids and hypertrophic scars have
marked alterations in ®broblast integrin expression
and contain several distinct populations of ®bro-
blasts. One of these populations expresses high levels
of a1 integrin, and the proportion of these cells is
higher in keloids (63% 6 3.6% SEM) and hyper-
trophic scars (45% 6 2.7% SEM) than in normal skin
tissues (28% 6 4.7% SEM). The different populations
of ®broblasts de®ned by integrin expression merge,
however, when the cells are serially cultured, sug-
gesting that there may be aspects of the dermal
microenvironment that maintain the integrin pheno-
typic heterogeneity in dermal ®broblasts. Key words:
VLA1/skin/myo®broblast. J Invest Dermatol 118:409±415,
2002
N
ormal wound healing in human skin is a process
that requires a balance of many cellular and
extracellular factors. Structural proteins and glyco-
proteins must be deposited and removed at
appropriate rates to ensure a healthy, functional
scar. In keloids and hypertrophic scars this balance is not
maintained, leading to a dramatic over-abundance of localized
collagen along with a variety of other alterations in dermal
structure. Both types of scars can cause pain, pruritis, and
dis®gurement, but they are distinct in that hypertrophic scars
do not grow beyond the original wound site whereas keloids
grow much larger and invade healthy dermal tissue (Rudolph,
1987). Skin ulcers that result from radiation therapy lie at the
opposite end of the scar healing spectrum. They lack the ability to
®ll in and heal spontaneously because local cells are permanently
damaged by the radiation (Rudolph et al, 1988, 1994). Although
lacking healing ability, radiation-damaged skin paradoxically ®rst
develops extensive ®brosis, and may then progress to frank
ulceration.
Extensive studies have been performed on keloids and
hypertrophic scars, concentrating primarily on extracellular col-
lagen and cell function (Niessen et al, 1999), but integrin expression
in these scars is unexplored. Integrins are a family of heterodimeric
transmembrane proteins that are the primary receptors for
extracellular matrix proteins (Hynes, 1992). They regulate many
aspects of cell behavior, including providing positive or negative
feedback on synthesis of the extracellular proteins themselves. It
therefore follows that faulty or absent integrins could be involved in
the etiology of keloids and hypertrophic scars.
Integrin a1b1 binds to ®brillar and non®brillar collagens and is
expressed predominantly by mesenchymal cells in the adult,
including ®broblasts, myo®broblasts (Gardner et al, 1996), smooth
muscle cells (Belkin et al, 1990), and microvascular endothelium
(De®lippi et al, 1991), as well as some T cells and macrophage/
monocytes (Hemler et al, 1985; de Fougerolles et al, 2000). Several
observations have suggested that negative feedback regulation of
collagen synthesis is a major role of integrin a1b1. Receptor
stimulation causes increased downregulation of collagen synthesis
(Langholz et al, 1995) by ®broblasts in collagen gels, whereas
antibody blockade of a1b1 prevents downregulation of collagen
synthesis (Ravanti et al, 1999). The integrin a1 null mouse has an
increase in steady state collagen production in the dermis, along
with an increase in metalloprotease synthesis (Gardner et al, 1999).
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Reductions in cell surface integrin a1 subunit were identi®ed in
lesional ®broblasts from patients with scleroderma, a disease whose
major pathologic endpoint is excess collagen deposition (Ivarsson
et al, 1993). Lastly, it has been observed that keloidal ®broblasts are
de®cient in collagen downregulation when suspended in collagen
gel (Sato et al, 1998), a hallmark of a1 null ®broblasts (Gardner et al,
1999).
Keloids make increased amounts of collagens I and III (Abergel
et al, 1985). Keloids and hypertrophic scars both have increased
collagen I transcription, and keloids have increases in steady state
collagen I message levels (Friedman et al, 1993). Some keloids also
have reduced collagen degradation (Abergel et al, 1985) with
abnormalities in matrix metalloprotease (MMP) levels including
upregulated MMP-2 and downregulated MMP-9 (Neely et al,
1999). Other abnormalities in the matrix include increased biglycan
but normal decorin levels (Hunzelmann et al, 1996), as well as
increased ®bronectin (Kischer and Hendrix, 1983). Abnormalities
in the local cytokine milieu are also evident, including increased
transforming growth factor b (Peltonen et al, 1991) and connective
tissue growth factor (Igarashi et al, 1996). Other abnormalities
noted include microvessel occlusion by endothelial cells in both
types of lesion (Kischer et al, 1982), and aberrant expression of
major histocompatibility complex class II in lesional ®broblasts of
hypertrophic scars (Castagnoli et al, 1990b). Keloids have a
predilection for darker skinned races, and hypertrophic scars appear
to be associated with human leukocyte antigen haplotype DRb16
(Castagnoli et al, 1990a).
We therefore initially hypothesized that ®broblasts in keloids
and hypertrophic scars might demonstrate an abnormal reduction
in integrin a1b1 expression, which could result in a loss of
negative feedback and could explain the increase in collagen
synthesis in these scars. As we had observed that the a1 null mice
were viable and fertile with remarkably few overt abnormalities
(Gardner et al, 1996), we considered the possibility that the
tendency to produce keloids or hypertrophic scars might even be
due to a null or hypomorph mutation in the human a1 gene in
certain individuals.
Integrin a2b1 is a collagen receptor favoring collagen I, and is
expressed predominantly on the basal surface of the epithelial cells
(Wu and Santoro, 1994), but is also found on ®broblasts (Gardner
et al, 1996), endothelial cells (De®lippi et al, 1991), a subset of T
cells in association with a1 (Meharra et al, 2000), and platelets
(Takada and Hemler, 1989). Upon binding to collagen I, integrin
a2b1 has been shown to upregulate the production of MMPs,
especially MMP-13 (Ravanti et al, 1999), as well as causing the
upregulation of synthesis of collagen itself (Langholz et al, 1995). As
MMP synthesis appears to be dysregulated in some aberrant scars, it
seemed possible that a2 expression might also be altered in these
lesions.
Integrin a5b1 is known to be expressed by several cell types and
is the major ®bronectin receptor in ®broblasts (Yang et al, 1993); its
ligand is known to be upregulated in keloids (Kischer and Hendrix,
1983). As we expected this receptor to be prominent on ®broblasts,
we chose it as a potential index for changes seen in the collagen
binding integrins, and as a control for detector drift between
specimens.
We examined the relative expressions of the two major
integrin collagen receptors a1b1, a2b1, as well as the major
®bronectin receptor a5b1, on the ®broblasts of keloids and
hypertrophic scars as a ®rst step toward understanding their possible
role in the formation of these aberrant scars. For comparison, we
examined expression of the same receptors on specimens of normal
skin and two radiation-induced skin ulcers. As cellular expression of
many surface markers can be modulated dramatically by tissue
culture, we devised a strategy for ®broblast isolation from the
specimens that avoided the step of explant culture. To determine
whether explant culture did in fact cause alteration of the integrin
expression pro®le, we determined the integrin pro®le in several
specimens not only upon ®rst isolation but also after successive
passages in culture.
MATERIALS AND METHODS
Cell harvest Keloids, hypertrophic scars, and radiation ulcers (Table I)
were collected from local hospitals and clinics immediately after surgery
and kept in a cool, sterile, saline environment for transport to the
laboratory. Normal skin was taken from discarded surgical specimens in
patients without problem scars (Table I). All tissues were mature enough
in their formation that they could be symptomatically de®ned by
category. Tissue harvesting was approved by the Human Subjects
Committees (Institutional Review Boards) at the relevant institutions as
``no risk'', i.e., using only discarded specimens from clinically indicated
surgery. Normally healing recent scars were not available during this
study, as there is usually little or no indication for surgical removal of
such scars. Mature scars (over 2 y old, n = 4) were also harvested, but
they did not yield suf®cient numbers of cells for this study.
A cross-section of each tissue was frozen in Tissue-Tek OCT
compound for histology and immuno¯uorescence, whereas the majority
of each tissue was placed in Dulbecco's phosphate-buffered saline
(PBS) + 0.25% trypsin and incubated overnight at 4°C. The epidermis
was then removed with a razor, leaving only the dermis, which was
diced and digested in Dulbecco's modi®ed Eagle's medium (DMEM) +
0.25% collagenase type I (Worthington Biochemical Company,
Lakewood, NJ) + 2.5 mM CaCl2, and shaken at 37°C for 1±2 h. The
digest solution was then passed through a 100 mm nylon mesh screen to
remove undigested fragments, and the ®ltrate was allowed to digest for
an additional 20 min at 37°C. Cells were recovered by centrifugation
and were washed in PBS prior to either culture or immunostaining for
¯uorescence-activated cell sorter (FACS) analysis. Cells were cultured in
high glucose DMEM + 10% fetal bovine serum at 37°C and passaged
with trypsin.
Antibodies Frozen sections (10 mm) were stained for immuno-
¯uorescence. Directly harvested and cultured cells were stained for FACS
analysis. Speci®cities of the antibodies used in FACS analysis were all
con®rmed using immunohistochemistry. For histology, 10 mm frozen
sections were thawed, OCT was washed away in PBS, and stains were
applied in PBS + 3% bovine serum albumin + 3% normal goat serum
(NGS) on ice for 40±60 min for each antibody. Antibodies used were as
follows: mouse antihuman a1 (Biogen, Cambridge, MA), directly
conjugated with Alexa 488 (Molecular Probes), mouse antihuman a2 or
a5, both phycoerythrin conjugated (Pharmingen, La Jolla, CA),
antihuman a6 (Chemicon, Temecula, CA), goat antimouse ¯uorescein
isothiocyanate (FITC) (Becton Dickinson, San Jose, CA), goat antimouse
FITC (Jackson Immuno Research, West Grove, PA), goat antimouse
CyChrome (Caltag Laboratories, Burlingame, CA), antihuman
procollagen type I (Chemicon), labeled with Alexa 488 (Molecular
Probes) according to the manufacturer's instructions, mouse antihuman
Von Willebrand Factor-8 (Daco, Denmark), mouse anti-a smooth
muscle actin FITC (Sigma, St. Louis, MO), rat antimouse (cross-reacts
with human) Mac-1 (Pharmingen, La Jolla, CA).
Flow cytometry
Antibody staining Staining for integrins was done in PBS + 3% bovine
serum albumin + 3% NGS on ice for 40±60 min for each antibody.
Cells were washed in PBS/2% fetal bovine serum/0.2% Na azide, and
®xed in PBS/4% paraformaldehyde.
FACS settings Data were collected on a Becton-Dickinson FACScan
using the argon 488 nm laser line. Data were acquired with the
following settings: FSC E00V, gain 2.07; SSC 335 V, gain 3.2; FL1
(530 nm) 610 V, log; FL2 (585 nm) 640 V, log; FL3 (670 nm) 660 V,
log. Compensations used were as follows: FL1 = 2% of FL2; FL2 = 15%
of FL1; FL3 = 14.7% of FL2.
General parameter adjustment Thresholds excluded tiny particles of
matrix and cell fragments from the pro®le. Larger particles, however,
created a visible line of auto¯uorescent events along the diagonal in the
majority of samples derived from primary digestion of tissue samples.
This auto¯uorescence could not be removed by gating and did not
resolve with adjustment of compensation values. We concluded that this
artifact was an inevitable hindrance when analyzing material derived
from primary digestion, and was probably worsened by the requirement,
in our facility, to ®x human samples prior to FACS analysis. Although
FACS pro®les show four to ®ve cell populations among the data, we
con®ned our numerical analysis to two major populations that were far
from the diagonal and were thus easily distinguishable from the
auto¯uorescent events. All specimens were examined using the same
FACScan machine and, after parameter adjustments for the ®rst few
samples, the settings were held constant throughout the period of study,
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during which time no laser or detector changes or adjustments were
made.
Identi®cation of ®broblasts We were most interested in the recovery of
®broblasts from the digested tissues, but we anticipated the likelihood of
contamination from endothelial cells, and also possibly residual basal and
adnexal epidermal cells. In order to distinguish endothelial and basal
epithelial cells from the others, all samples were examined using anti-
integrin a6 in the far-red channel (Fig 1). These cells were then
eliminated from the ¯ow cytometric analysis using a gating function that
was included in the analysis software. The speci®city of this antibody for
epithelial and endothelial structures was con®rmed by immuno-
¯uorescence. Histologic examination of the specimens revealed little or
no in¯ammation and occasional specimens were stained with anti-Mac1
and anti-CD3 to con®rm the absence of monocytes/macrophages and
T cells histologically and by FACS analysis (not shown).
RESULTS
Histology
Normal skin Integrin a1 expression was con®ned to the dermal
capillary network, with faint staining occasionally visible in the
papillary dermis. a2 was faintly expressed also in the papillary
dermis, and abundantly in basal epithelial cells and dermal
appendages with moderate expression in dermal capillaries. a5, as
expected, was abundant in basal epithelial cells, as well as being
present on dermal ®broblasts (Fig 2A). Staining for a5 in
®broblasts was far more abundant than for the collagen binding
subunits, and again in contrast to a1 and a2 was abundant in the
reticular dermis.
Keloids and hypertrophic scars Keloids had characteristic whorled
collagen bundles in the deeper dermis, along with an expansion of
the papillary dermis, although it was notable that the two dermal
layers continued to be quite distinct from one another. Several
other histologic features were evident, including epidermal
thickening and lengthening of rete pegs and, most evident under
Table I. Specimens used in the study
Tissue Ethnicity Gender Age Location Comments and history of scar
Normal skin white female 51 breast
white female 54 breast
white female 56 abdomen
white female 63 abdomen
white female 64 face
white female 66 abdomen
white female 72 face
white female 72 face
Hypertrophic scars white female 66 ear slow growth, pruritic, prior steroid injection
Hispanic male 2 neck scalded, growing and pruritic, prior steroid tape and pressure
Hispanic male 48 hand raised, pruritic, prior silicone sheet, pressure, and 585 pulse laser
Philip. female 41 abdomen present 2 y, increase in size within last 2 mo, three treatments of steroids with no change/
very slow growth
Af.-Am. female 38 chest
Keloids white
white
female
male
22
41
ear
chest
large (3 cm diam. sphere)
present 10 y, treated with steroid with increase in size, number and size of stellate
projections increased in last year
white male 64 ear present 15 mo, prior steroid injection with slow growth
Philip. male 44 chest present 2 + y, no active growth, pruritic
Af.-Am. female 21 ear present several year, prior excision and steroid injection, rapid growth followed
Af.-Am. female 22 chest present 5 y, recent increase in size (6 3 12 cm), pruritis (appears in Fig 2B)
Af.-Am. female 35 face recurring, one on each side of face and one on neck
Af.-Am. male 12 ear present 5 y, previous excision and steroid injections with rapid growth last 2 y
(appears in Fig 2D)
Af.-Am. male 25 head present 6 y, steroid treatment, no recent change (2.5 3 3.5 cm) (appears in Fig 2C, E, F)
Af.-Am. male 25 jawline present 1.5 y, no treatment, no change in size (2.5 3 5 cm)
Af.-Am. male 33 ear present 1 y, no treatment, no growth
rad. ulcers Hispanic female 48 breast present 1 y, painful, nonhealing
Hispanic female 58 breast present 2 + y, painful, nonhealing
Figure 1. Removing epithelial and endothelial cells. (A) HaCaT
cells are used as a positive control for a6 staining. The left histogram
shows the 2° stain alone whereas the right histogram shows positive
staining with the anti-a6 IgG. (B) Cells from a typical keloid, triple
staining for a1, a2, a6. The a6-positive region is marked on the
histogram and, whereas the a1±a2 dot plot shows the a6-positive events
in red, the majority of the a6-positive cells (which are most likely to be
endothelial) are a subset of the a1 low±intermediate, a2/a5 high
population (population 2 in subsequent ®gures).
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¯uorescence, loss of normal bundles of elastic ®bers. In occasional
keloid specimens vascular changes were quite prominent with
enlargement and ectasia of dermal vessels, which were sometimes
surrounded by regions of denser cellularity; these regions were
smooth muscle actin positive (Fig 2E) and consistent with pericyte
or myo®broblastic differentiation. In¯ammation was minimal in
almost all specimens examined. In contrast to keloids, the
hypertrophic scars examined were not marked by the destruction
of elastic ®bers and, overall, the accumulated connective tissue
appeared looser in structure.
In keloids, a striking upregulation of all three integrins was
evident in the ®broblast compartment. a2 (not shown) and
particularly a1 (Fig 2B) staining was far stronger than in normal
tissues, and extended with equal strength into the reticular dermis,
whereas reticular dermal staining was never seen in the normal
samples. The distribution of a1 and a2 staining was diffuse (other
than the very high levels of a1 seen in perivascular regions of a
minority of keloids) and therefore we concluded that the high a1
expressing population identi®ed in all keloids by FACS was
diffusely distributed and was not con®ned to a particular dermal
compartment. In keeping with previous observations (Ehrlich et al,
1994) we did not see smooth muscle actin expressed in keloidal
®broblasts, with the exception of the perivascular myo®broblastic
cells (Fig 2E, F) noted in occasional specimens as described above,
which coexpressed a1 and smooth muscle actin. Upregulation of
integrins was similar in the hypertrophic scars examined.
Integrin expression Using multiple antibodies for FACS
analysis, we were able to distinguish several cell populations in
each tissue type (Figs 3, 4). Of these, two populations were
Figure 2. Immuno¯uorescent staining of tissues (see Table I). All samples were examined and photographed through a triple wavelength ®lter
cube. Magni®cations refer to objective compounded by ocular magni®cations. (A)Normal skin sample. Note the auto¯uorescence of abundant dermal
elastic ®bers. Left panel: a1-A488, a2-PE, 20x. Faint a1 and a2 staining is seen in the papillary dermis. a2 is abundant in the basal epidermis. Right
lower panel: a1-A488, 40x. a1 stains the medium of a deep dermal artery. Right upper panel: a5-PE, 20x. a5 is diffusely distributed throughout the
reticular dermis. (B) Keloid, a1-PE, DAPI, 10x. a1 is abundant and distributed throughout the papillary and reticular dermis. (C) Keloid, a1-PE,
procollagen-A488, 20x. Note the colocalization of these markers in a cellular region of the keloid. (D) Keloid, a5-PE, procollagen-A488, 20x. a5 and
procollagen staining are similarly colocalized. (E) Keloid, a1-PE, smooth muscle actin FITC, 20x. This keloid was one of a minority with palisades of
a1-positive, smooth-muscle-actin-positive myo®broblasts surrounding dermal vessels. The majority of specimens were smooth muscle actin negative
consistent with Ehrlich et al (1994). (F) Same specimen as (E), a1-PE, procollagen-A488, DAPI, 40x. At the center of the palisade cells express high
amounts of a1 and collagen, and may be myo®broblasts, or possibly also endothelial cells as previously observed by Peltonen et al (1991).
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especially prominent and easily quanti®able: population 1 had high
a1, and low a2 and a5 (Fig 4C); population 2 had high a2 and
a5, and low a1 (Fig 4C).
Pro®les of a2 versus a1 were largely similar to pro®les of a5
versus a1, suggesting that a2 and a5 were coordinately expressed.
We tested this by staining several specimens simultaneously with
a2-PE and a5-FITC. A dot plot of a2 versus a5 in these specimens
(Fig 4B) con®rmed coordinate expression. As we observed that
cells marking with the anti-a6 antibody appeared to be a1 low±
intermediate and a5/2 high, or a subset of population 2, we
considered the possibility that the whole of population 2 might be
endothelial derived, and that a proportion of it was failing to stain
with anti-a6. The abundance of this population in different tissues,
however, did not correlate with the vessel density seen by
immuno¯uorescent staining with anti-a6, nor with the proportion
of a6-positive cells by ¯ow cytometry. We therefore concluded
that population 2, after gating out a6-positive cells, did indeed
consist of ®broblasts.
Changes in the other cell populations were also present,
including a reduction in the proportion of cells expressing very
low surface integrin levels (Fig 4). These changes were harder to
quantify, however, as the cells in these populations overlapped with
auto¯uorescent debris. We therefore con®ned our numerical
analysis to a comparison of the number of cells in populations 1
and 2 in each specimen (Fig 4A), and to the level of expression of
each integrin (measurable as ¯uorescence intensity). We compared
the populations as ratios of each other, as opposed to comparing
them with the total number of events, because the total events
included auto¯uorescent debris, which varied between specimens.
The analysis revealed that the proportion of cells expressing high
a1 levels (population 1) was elevated in keloids (63% 6 3.6%
SEM), hypertrophic scars (45% 6 2.7% SEM), and radiation-
induced ulcers (39%) relative to normal tissues (28% 6 4.7% SEM),
with the greatest proportion in keloids and the smallest in the
radiation ulcer specimens. In contrast, when mean a1 levels of
expression of population 1 were determined, the highest levels
were seen in the radiation ulcer specimens (1957 ¯uorescence
intensity units, f.i.u.), with intermediate levels in keloids (1513
f.i.u.) and hypertrophic scars (1525 f.i.u.) (Fig 5B). In other words,
the proportion of cells in population 1 (the high a1 expressing
cells) did not correlate with the mean level of expression in that
population.
Effects of cell culture Our method for harvesting ®broblasts
gave high yield while avoiding the need for explant culture. This
proved to be essential as the integrin expression patterns began to
change dramatically once the cells were passaged in culture. The
heterogeneous integrin pattern seen in ¯ow cytometric analysis of
the directly harvested keloid cells, for example, became more
homogeneous with each successive passage in culture (Fig 6A). By
the fourth passage, the two distinct ®broblast populations 1 and 2
could no longer be distinguished from one another, revealing
instead a homogeneous population expressing relatively large
amounts of all three integrins examined (Fig 6 shows a1 versus
a5; a1 versus a2 not shown). It would have been desirable to
examine the progression of integrin expression in populations 1 and
2 separately. Unfortunately, this would have required cytometric
separation of un®xed human cells, which contravened institutional
guidelines.
It can be seen that the FACS dot plots do not show an obvious
loss of one population over another but instead the development,
Figure 3. Density plots for a typical keloid specimen stained
singly or in combination, with the integrin antibodies or the
isotype controls. ``Iso'' indicates isotype control antibody.
Figure 4. Integrin expression in normal skin and keloids. (A) A
gallery of FACS pro®les showing the variation between several normal
and keloid specimens. First and second columns are a1 versus a2, and
third and fourth columns are a1 versus a5. First and third columns are
normal skin samples; second and fourth are keloids. Note the marked
increase in population 1 (the a1 high a2/5 low population) in the
keloids. A pattern similar to the keloids was seen in hypertrophic scars
and radiation ulcers. (B) An example of a keloid specimen costained with
anti-a2-FITC and anti-a5-PE. a2 and a5 appear to be coexpressed.
This costain was performed on two other specimens with similar results.
(C) Enlargement of a panel from (A) showing de®nitions of populations
1 (high a1, low a2/a5) and 2 (high a2/5, low a1).
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with successive passages, of a population with a new and relatively
homogeneous staining pro®le. We were surprised to see the same
homogeneous expression pattern appear in keloid, hypertrophic
scar (not shown), and normal ®broblasts (Fig 6B) when each had
been cultured through four passages, suggesting that dermal
®broblasts adopt a default state on tissue culture plastic. We
addressed this by culturing some samples from initial isolation on
both polymeric (100 mg per ml in PBS) collagen I and ®bronectin
rather than tissue culture plastic; however, these too moved toward
a similar default state (not shown).
DISCUSSION
The integrin expression pro®les of keloids, hypertrophic scars, and
radiation ulcers were remarkably stereotypical, and consistent
enough that we could distinguish them from normal skin samples
by FACS pro®les alone. The striking hallmark of all wound
specimens including radiation ulcers was the prominence of a high
a1, low a2/5 expressing population of cells (population 1) (Fig 4),
which was signi®cantly less evident in normal skin (Fig 5A). A
different population that expressed low a1, high a2/5 (population
2) appears to be common to all tissues examined, although an
increase in mean level of a2 and particularly a5 expression was
evident in this population in the aberrant scars and ulcers (Fig 5B).
There was no obvious segregation between populations 1 and 2
into different compartments of the dermis when samples were
examined by immuno¯uorescence. The appearance of an integrin
a1b1 expressing subset of dermal ®broblasts may be common to all
types of dermal injury. Our ¯ow cytometric analysis, however,
suggests that the proportion of cells in this population is highest in
the wounds with the most exuberant scarring, namely keloids
(63% 6 3.6%), and possibly lowest in chronic radiation ulcers
(39%), which are characterized by a de®ciency in healing.
Hypertrophic scars differ from keloids in that they will not grow
beyond the original wound site into healthy tissue and will often
regress with time, and several other distinctions have been made
between the two lesions (Heino et al, 1989). In this study, it is
notable that the proportion of population 1 cells (high a1, low a2/
5) in hypertrophic scars (45% 6 2.7%) is appreciably lower than in
keloids (63% 6 3.6%). The mean levels of expression of a1 in
these populations, however, followed a reverse trend with the
highest level being expressed in radiation ulcers. The importance of
this reverse trend is not clear, as only two radiation ulcers were
available for study.
As integrin a1b1 is a feedback inhibitor of collagen synthesis, we
had ®rst hypothesized that this receptor would be downregulated or
even absent in keloids. This seemed plausible, as a1 null mice are
viable with few overt phenotypic anomalies (Gardner et al, 1996).
Instead, keloids were found to contain the largest subset of
®broblasts that expressed a1b1 integrin. The ®nding that both
integrins and collagen synthesis are upregulated in both keloids and
hypertrophic scars is consistent with what would be expected in
response to elevated levels of the pro®brotic cytokine transforming
growth factor b, as the latter has been shown to upregulate surface
integrin expression (Babu et al, 1992) and cause upregulated
collagen synthesis. In keloids, the high integrin patterns are
compatible with the well-described aberrant cytokine milieu
(Peltonen et al, 1991) and the high proportion of a1-positive
cells in keloids may be consistent with the altered cytokine response
pattern that is described in these lesions (Niessen et al, 1999).
Although demonstrating the presence of abundant immunoreactive
a1 on keloidal ®broblasts, our study cannot rule out the possibility
that the a1 seen is mutated and nonfunctional, preventing collagen
synthesis regulation, although this seems unlikely.
Cells from all three types of tissue examined undergo a dramatic
homogenization in integrin expression when they are cultured.
Other researchers have seen a similar phenomenon in a-smooth
muscle actin expression in cultured ®broblasts (Ehrlich et al, 1998)
and in integrin expression in cultured smooth muscle (Yamamoto
and Yamamoto, 1994). Such ®ndings lead us to suggest that, in
keloids, hypertrophic scars, and radiation ulcers, the extracellular
milieu may be crucial to the maintenance of ®broblast integrin
expression.
Figure 5. Summary of high integrin a1 expression in different
tissue types. Bars and errors indicate the mean and SEM (SEM is not
included for radiation ulcers due to small sample size). (A) The
proportion of highly a1 events (population 1) is expressed as a ratio of
cells in population 1 to cells in populations 1 + 2, calculated from the
a1 versus a2 dot plots of each specimen. Both keloids and hypertrophic
scars have a signi®cant increase in the size of population 1 relative to
normals (p < 0.05) (n = 8 for normal skin, 11 for keloids, 5 for
hypertrophic scars, and 2 for radiation ulcers). (B) Intensity of a1
expression in population 1. Fluorescence intensity is signi®cantly higher
for keloids and hypertrophic scars than for normal skin samples (p
< 0.05) (some early specimens were not used in this calculation because
they were processed at incomparable ampli®cation settings; n = 3 for
normal skin, 7 for keloids, 4 for hypertrophic scars, and 2 for radiation
ulcers). Radiation ulcers not included in statistical tests for signi®cance
due to small sample size.
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Figure 6. FACS pro®les showing the effects
of culturing directly harvested ®broblasts on
plastic. (A) Successive passages show the
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monomorphic population. (B) Sample of normal
skin and a keloid. Normals, keloids, and
hypertrophic scars (not shown) look similar after
passage four, suggesting a ``default'' integrin
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